K Charles Janac Sells 11,821 Shares of Arteris (NASDAQ:AIP) Stock

Key Points

• Arteris CEO K Charles Janac sold 11,821 shares of the company's stock at an average price of $11.07, totaling $130,858.47, resulting in a 6.59% decrease in his holding.
• Arteris has reported a negative return on equity of 8,546.17% and earnings per share (EPS) of ($0.11), meeting analysts' expectations for the quarter.
• Despite mixed ratings from analysts, Arteris holds a consensus rating of "Moderate Buy" with a price target increase to $15.00 from a previous estimate of $12.00.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) CEO K Charles Janac sold 11,821 shares of the company's stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $11.07, for a total value of $130,858.47. Following the completion of the transaction, the chief executive officer owned 167,514 shares of the company's stock, valued at $1,854,379.98. This trade represents a 6.59% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

K Charles Janac also recently made the following trade(s):

• On Thursday, October 2nd, K Charles Janac sold 7,147 shares of Arteris stock. The shares were sold at an average price of $10.92, for a total value of $78,045.24.
• On Thursday, September 4th, K Charles Janac sold 2,057 shares of Arteris stock. The shares were sold at an average price of $8.73, for a total value of $17,957.61.
• On Tuesday, September 2nd, K Charles Janac sold 1,246 shares of Arteris stock. The shares were sold at an average price of $8.94, for a total value of $11,139.24.
• On Tuesday, August 5th, K Charles Janac sold 50,000 shares of Arteris stock. The shares were sold at an average price of $13.12, for a total value of $656,000.00.
• On Tuesday, August 5th, K Charles Janac sold 94,245 shares of Arteris stock. The shares were sold at an average price of $13.49, for a total value of $1,271,365.05.

Arteris Stock Performance

NASDAQ:AIP traded up $2.60 during trading on Monday, reaching $13.58. The company's stock had a trading volume of 4,397,458 shares, compared to its average volume of 565,523. The firm has a market cap of $579.19 million, a price-to-earnings ratio of -16.56 and a beta of 1.45. The firm has a 50 day moving average of $9.65 and a 200-day moving average of $8.43. Arteris, Inc. has a 12 month low of $5.46 and a 12 month high of $14.58.

Arteris (NASDAQ:AIP - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The firm had revenue of $16.50 million during the quarter, compared to the consensus estimate of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Arteris in the 1st quarter valued at about $95,000. Acadian Asset Management LLC raised its holdings in shares of Arteris by 40.6% in the 1st quarter. Acadian Asset Management LLC now owns 900,723 shares of the company's stock valued at $6,222,000 after acquiring an additional 260,277 shares in the last quarter. Jacobs Levy Equity Management Inc. raised its holdings in shares of Arteris by 48.5% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 249,517 shares of the company's stock valued at $1,724,000 after acquiring an additional 81,516 shares in the last quarter. Squarepoint Ops LLC purchased a new stake in shares of Arteris in the 4th quarter valued at about $160,000. Finally, Nuveen LLC purchased a new stake in shares of Arteris in the 1st quarter valued at about $349,000. Institutional investors own 64.36% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on AIP shares. Wall Street Zen raised shares of Arteris from a "sell" rating to a "hold" rating in a report on Monday, September 15th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Arteris in a report on Saturday, September 27th. Finally, TD Cowen upped their price objective on shares of Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $15.00.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.